Work

SA30 Symptom Burden and Healthcare Resource Use in Claudin 18.2+ (CLDN18.2+), HER2− Patients With Locally Advanced (LA) Unresectable or Metastatic Gastric or Gastroesophageal Junction (mG/GEJ) Adenocarcinoma

Year: 2024

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2024.03.1877

Authors: M Sewastjanow-Silva, JE Rogers, RE Waters, Vicentini E Rosa, T Totev, EQ Wu, H Yang, L Chang, M Oh, J Ajani

Institutions: The University of Texas MD Anderson Cancer Center, Analysis Group (United States), Astellas Pharma (United States)

Language: English

Topic: Gastric Cancer Management and Outcomes

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4399706947

Cites:

Cited by:

Related to: 10